Time frame sensitivity of a point-of-care test to monitor isoniazid adherence in TB treatment Source: Annual Congress 2009 - Diagnostic advances in tuberculosis Year: 2009
IP-10 point-of-care tests for monitoring treatment efficacy in tuberculosis in a low-resource setting Source: International Congress 2017 – Update on TB: latest news Year: 2017
Evaluation of patient adherence to tuberculosis treatment by measuring drug metabolites in urine Source: Eur Respir J 2004; 24: Suppl. 48, 649s Year: 2004
Drug-susceptibility testing in tuberculosis: methods and reliability of results Source: Eur Respir J 2005; 25: 564-569 Year: 2005
Rapid diagnosis of tuberculosis and rifampin resistance by GeneXpert MTB/RIF test Source: International Congress 2018 – Diagnosis of tuberculosis Year: 2018
Direct molecular testing for isoniazid and rifampicin resistance from respiratory specimens of patients with tuberculosis Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management III Year: 2013
Assessment of the clinical utility of amplicor mycobacterium tuberculosis direct test during bacteriological confirmation of tuberculosis in children Source: Annual Congress 2008 - Specific tuberculosis management problems in children and adolescents Year: 2008
Comparison of genotype MTBDRplus assay for rapid detection of rifampicin and isoniazid resistance with conventional drug susceptibility tests in a tertiary care hospital in India Source: International Congress 2016 – Microbiology: bronchoalveolar lavage (BAL) and PCR Year: 2016
Therapeutic drug monitoring of isoniazid, rifampin, and pyrazinamide in HIV-infected patients with tuberculosis Source: Annual Congress 2012 - Tuberculosis: clinical findings III Year: 2012
Dose optimisation of first-line tuberculosis drugs using therapeutic drug monitoring in saliva: feasible for rifampicin, not for isoniazid Source: Eur Respir J, 56 (4) 2000803; 10.1183/13993003.00803-2020 Year: 2020
The effectiveness of the introduction of the updated treatment regimens and microbiological diagnostics MDR/XDR tuberculosis Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II Year: 2019
Effect of HIV counseling and testing program on patients‘ adherence of isoniazid preventive therapy (IPT) Source: Eur Respir J 2005; 26: Suppl. 49, 455s Year: 2005
Detection of isoniazid or rifampin resistant Mycobacterium tuberculosis in patients with cavity and previously treated for tuberculosis - usefulness of rapid drug susceptibility test with sputum samples by reverse hybridization assay Source: Annual Congress 2005 - Resistant and multidrug resistant tuberculosis Year: 2005
Effectiveness of intravenous isoniazid and ethambutol administration in patients with new smear positive drug-susceptible pulmonary tuberculosis with tuberculous meningoencephalitis and HIV co-infection in the intensive phase of treatment Source: International Congress 2019 – Tuberculosis: treatment and management Year: 2019
An audit of adherence to antituberculous drugs using a new, rapid, point of care test for isoniazid metabolites Source: Eur Respir J 2002; 20: Suppl. 38, 566s Year: 2002
Evaluation of a molecular assay for detection of rifampin and isoniazid resistant mycobacterium tuberculosis in strains and clinical samples Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis Year: 2008
Patient choice promotes adherence in preventive treatment for latent tuberculosis Source: Eur Respir J 2007; 30: 728-735 Year: 2007
Clinical utility of glutaraldehyde gelification test as screening test for pulmonary tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 169s Year: 2002
Multidrug-resistant tuberculosis treatment failure detection depends on monitoring interval and microbiological method Source: Eur Respir J 2016; 48: 1160-1170 Year: 2016
Evaluation of therapeutic response in isoniazid resistant TB Source: Eur Respir J 2006; 28: Suppl. 50, 846s Year: 2006